However, SP antagonism may also be considered in HIV infection and tumors since SP facilitates HIV infection of macrophages by inducing CD163 expression57, 58, and tumor associated macrophages are more like M2-phenotype macrophages, which could be strategically blocked by an NK-1R antagonist. Here, TACR1 is linked to neoplasm.